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Clinical And Radiographic Evaluation of periodontal Infrabony Defects Treated 
With chitosan In Periodontitis Patients 
Abstract 
Chitosan is a naturally derived polymer that has been investigated for its uses as a biomaterial for drug 
delivery and anti-inflammatory. Recently, chitosan applications in bone regeneration has gained distinct 
interest. The aim of this study was to. evaluate clinically and radiographically the healing of the periodontal 
infra-bony defects using chitosan gel in periodontitis patients .Material & methods: Twenty periodontitis 
patients with bilateral infrabony defects having stage II and Stage III periodontitis were selected according 
to the criteria of AAP (2017) classification system of periodontal diseases and conditions. Using split 
mouth design, 20 defects were treated using chitosan gel; while contra-lateral defects were treated by 
flap only. A total of 40 periodontal infra-bony defects. were randomly assigned for treatment. The clinical 
parameters included clinical probing pocket depths and clinical attachment levels. Standardized periapical 
radiographs were recorded at baseline and 6 months after surgery. Results: The results were statistically 
analyzed and clinical and radiographic data. revealed a statistically significant difference between Chitosan 
and control sites in the parameters investigated with a significant bone fills versus baseline measurements 
(P < 0.05).Conclusion: Chitosan gel showed promising benefit in the periodontal regeneration context 
among periodontitis patients. 
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 1. INTRODUCTION  
Innovative approaches for the management of periodontal bone loss are being developed; 
chitosan become a potential new target for periodontal therapy. (Bartold, Cantley, & Haynes, 2010). 
Chitosan is a hydrophilic biopolymer acquired by alkaline deacetylation of chitin,. It is major 
component of arthropod shells, and has been declared as bioadhesive and permeabilizer. Chitosan 
advantages include nontoxic, biocompatible, and biodegradable. Chitosan attract attention in various 
dental specialties due to antimicrobial activity; wound healing enhancement, hemostatic, and tissue 
regeneration properties. (Aksungura et al., 2004; Boynueğri et al., 2009)   
Because of its bioadhesive and antimicrobial properties, chitosan containing formulations may 
remain for long-lasting time and also prevent any. Possible infection after periodontal surgery. 
(Cicciù et al., 2019; Matarese et al., 2017)  
Its tissue regeneration ability and hemostatic properties also eliminate any need for additional 
material. This enable dentists to spend less time in operations and offer more economical treatment 
modality for the patient. (Pippi et al., 2017) Advantages of chitosan include its self-adhesive nature 
and ability to be placed even on actively bleeding surface even in patients with bleeding disorders. It 
prevents wound from getting exposed to outside environment with residual acetic acid release was 
proved to reduce pain.(Boynueğri et al., 2009; G İkincia et al., 2002; Shen et al., 2006; Shin et al., 
2005)  
According to clinical studies, chitosan can be provided on a variety of methods where ideally 
6 months follow up after the baseline treatment as well as 3 month period maintenance post-
operatively is required to show significant improved bone behaviour on the tested oral areas, where 
decreased tissue inflammation and bleeding by probing (BOP) can be observed clinically as 
radiographic attachment levels can be enhanced concurrently.  (Wohlfahrt, Aass, & Koldsland, 2019)  
To our knowledge, limited number of researches has evaluated clinically and radiographically 
chitosan gel application in the treatment of periodontitis. 
1.1 The Aim of Study 
 
This study aimed to evaluate clinically and radiographically the healing of the periodontal 
infra-bony defects using chitosan gel in periodontitis patients. 
2. MATERIALS AND METHODS 
 
Twenty periodontitis patients with bilateral infra-bony defects were enrolled in the study from 
the Periodontology clinic at the Faculty of Dentistry, BAU. The study was approved by the 
Institutional Review Board at Beirut Arab University- Lebanon with IRB Number 2019H-0071-HS-
M-00315 patients signed a consent form indicating acceptance to join  the study after discussing  the 
benefits, risks, and alternative treatment modalities.  
Exclusion criteria include: Pregnancy or during lactation period, allergy to Chitosan, intake of 
antibiotics or anti-inflammatory drugs 6 months prior treatment, smokers’ patients, history of 
periodontal therapy 3 months before the treatment and history of any systemic diseases that would 
affect bone healing. 
These patients were chosen according to the criteria of the American Academy of 
Periodontology (2017) (Papapanou et al., 2018) and included periodontitis patients having moderate 
to advanced loss of periodontal tissue with bilateral infra-bony defects .  
2.1 Clinical Parameters 
 
Forty periodontal infra-bony defects were randomly treated using split mouth design, 20 
defects were treated in each patient using chitosan gel; while contra-lateral control sites defects 
were treated by flap only. Clinical probing pocket depths, clinical attachment level.  In addition 
to, standardized periapical x-rays were taken at baseline and 6 months after surgery. 
2.2 Radiographic Evaluation 
 
Standardized periapical radiographs were taken to the teeth included in the study before 
treatment procedures and. 6 months after the surgery. An individual silicon bite stent and a film 
holder device, in which the X-ray .tube-fitted were used with the purpose of standardization. 
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 Radiographic infra-bony defect depth were represented by  calculating the distance between the 
.(CEJ) and the bottom of the bone defect in a line parallel to the long axis of the tooth 
immediately adjacent to the proximal location being measured.(Boynueğri et al., 2009) 
2.3 Preparation of the (10%) Chitosan Gel 
 
A solvent was formed by mixing 1% glacial acetic acid solution and glycerol in a ratio of 
1 part of acetic acid solution to 3 parts of glycerol.  Then, one gram of fine powder chitosan was 
dissolved in 100 ml of the aforesaid solvent by stirring for one to two hours with a magnetic 
stirrer at room temperature. The formed clear pale yellow solution was neutralized by adding 5N 
NaOH until pH 7 was reached. Instantly, a clear slightly tacky gel formed as a result of the 
ingredient interaction of chitosan, glycerol and water. The gel has a three dimensional structure, 
and no free water or glycerol is apparent.(Boynueğri et al., 2009) 
2.4 Treatment procedures 
 
All patients received complete dental examination including medical and dental history, 
full mouth periodontal charting, and comprehensive treatment plan. Prior to surgical procedures, 
patients were recalled at weekly interval to receive optimum oral hygiene including deep gingival 
scaling and root planning using hand and ultrasonic instruments, rubber cup polishing and oral 
hygiene instructions. After initial therapy completion, the patients were re-evaluated to review 
the criteria for surgery. Surgical procedures were carried out under local anesthesia. After raising 
the periodontal flap, debridement & root planning were done with hand instruments, the defects 
were rinsed with sterile saline. Chitosan were added without overfilling the defect. Finally the 
flaps were repositioned coronally and closed with 4/0 silk mattress sutures.(Figures 1-6) The 
contra-lateral defects similarly were surgically treated but without the application of Chitosan. 
 
 
        Fig.1:  Periapical x-ray showing upper poster right segment with infrabony  
defect related to the first molar 
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Fig.2:  Preoperative picture, showing the calibrated periodontal prob measuring 7 mm  
probing pocket infrabony defect 
 
 
 
 
 
Fig.3: During periodontal surgery, showing flap reflection with infrabony defect 
 in the mesial surface of upper first molar 
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Fig.4: Chitosan gel application in the infrabony defect 
 
 
 
 
Fig.5: Bony defect filled with chitosan gel 
 
4
BAU Journal - Creative Sustainable Development, Vol. 1, Iss. 2 [2020], Art. 4
https://digitalcommons.bau.edu.lb/csdjournal/vol1/iss2/4
 
 
Fig.6: Flap repositioned coronally and closed with 4/0 silk suture  
 
2.5 Postoperative Care 
Prescription of (amoxicillin 500 mg, t.i.d.)  for 1 week after surgery and .2% chlorhexidine 
mouth rinse twice daily for two weeks was given the patient.  The suture removal was done after 
7–10 days.  Scheduled appointments were every second week for 2 months after surgery.  And 
once a month up to four months for clinical and radiographic reevaluation (Figures 7 and 8). 
2.6 Statistical Analysis 
Data were analyzed using SPSS Statistics software, version 23.0.0. Variations in the 
clinical and radiographic parameters investigated over time were assessed using repeated-
measures analysis of variance. Intragroup comparisons at 6 months, versus baseline 
measurements .were conducted using the paired t-test. Intergroup comparisons of parameters 
change investigated compared to baseline were performed using Student’s t-test. The 
significance level was set at P < .05. 
3. RESULTS 
Twenty periodontitis patients (15 females and five males) participated in the study. Their age 
ranged from 33 to 49 years. They had at least ten sites with more than five mm of clinical attachment 
loss on at least two teeth per quadrant as well as radiographic evidence of bone loss of more than 
one-third of the root length. Two contra-lateral periodontal infra-bony defects, with probing depths. 
more than six mm and radiographic evidence of bone loss of at least three mm  . A total of 40 infra-
bony defects were treated. No inflammatory reactions were observed following the application of 
chitosan gel during maintenance visits.  
Table 1 shows the clinical probing depth of the Chitosan sites and Control sites at various time.  
At baseline, there was no statistical significant difference between chitosan and control sites 
regarding the mean and SD of both clinical probing depths and attachment levels (P>0.05). At 6 
months both sites showed significant improvement in clinical parameters over baseline values. 
Statistically significant difference when the two sites where compared. (P < 0.05). 
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 Table 1: The clinical parameters of the Chitosan sites versus control sites at time intervals 
 
Clinical parameters 
Baseline 
 
Chitosan sites Control sites 
Baseline 
 At 6 
months 
Baseline At 6 months 
Clinical 
probing 
depth 
Range 6–10 3–5 6–10 4–6 
Mean± SD 8.48±0.5* 3.9±0.7** 8.83±0.34 5.1±0.8 
Clinical attachment 
level 
Range 6–9 4–6 6–9 5–7 
Mean± SD 7.21±0.35* 4.85±0.65** 7.75±0.96 5.78±0.88 
  
Chitosan sites versus Control sites at:  *Baseline,. not significant   **six months, P<0.05 significant 
 
Table 2 shows the radiographic infra-bony defects depth of the Chitosan sites and the. control 
sites at. various time intervals. At baseline, regarding.the radiological depth of infra-bony defects 
there was no statistical difference between Chitosan and control sites   (P>0.05).  At 6 months, both 
sites showed defect fill with depth reduction over baseline measurements. Statistically significant 
difference between.Chitosan and control sites when compared (P<0.05). 
 
 
Table 2: The radiographic infra-bony defects depth of chitosan sites .and control sites  
at various time intervals 
 
 Chitosan sites Control sites 
 At 
baseline
* 
At 
6months** 
Defect 
fill 
Defect 
resolution 
(%) 
At baseline At 6 
months 
Defect fill Defect resolution  
(%) 
Range 3.5–7.5 1.5–4 1.5–3.5 36.5–62.5%, 3.5–7.5 4.0–4.5 0.5–1.5 10.2-20.5% 
Mean
± SD 
5.1±0.
5 
2.2±0.6 2.8±0.4 56.75±12.5
%. 
5.2±0.6 4.2±0.2 0.8±0.3 15.5±4.5%. 
  
Chitosan sites versus Control sites at:  *Baseline, not significant     **six months,. P<0.05 significant 
 
 
 
Fig.7: Preoperative periapical radiograph from 
periodontitis patient in the Chitosan sites, 
showing a 5 mm deep infra-bony defect on 
the distal surface of the first lower right 
molar 
Fig.8:  Six months postoperatively, showing     
           evidence of 3 mm defect fill  
 
Reference: Photographed by the author July 2015 
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4. DISCUSSION  
Chitosan has been reported according to many studies as effective biodegradable and 
biocompatible substance in repairing bone defects. Chitosan can be used as a biocompatible coating 
for orthopedic and dental implants with minimal inflammation reported. Moreover, Chitosan 
microparticles improved drug delivery that increase and accelerate bone growth. (Ezoddini-
Ardakani, Navab Azam, Yassaei, Fatehi, & Rouhi, 2011; Kung et al., 2011; Y.-M. Lee et al., 2000) 
Chitosan has been used in combination with different local dental biomaterials such as Glass 
ionomer cement (GIC) centrimide with chlorhexidine to intervene with bacterial-host interaction 
preventing the progression of caries, as well as dexpanthenol gel to enhance wound healing and 
certain oral anti-fungal mouth rinses, as chitosan contains itself potent anti-fungal properties. A 
specific chitosan brush would be necessary to deliver local applications of the formula. Bone repair 
and regeneration are possible due to the biocompatibility and non-digestive chitosan properties as 
mentioned earlier. (Mishra, Pandey, & Manickam, 2017; Pippi, Santoro, & Cafolla, 2017) 
    Based on a lot of studies investigated effects of chitosan on bone healing, various theories 
on its mechanisms was pustulated. Such as,. chitosan increases vascularization of blood vessels and 
stimulates budding tissue. . (Chevrier, Hoemann, Sun, & Buschmann, 2007; Zhao et al., 2012) 
Also, chitosan might be used on systemic deliveries with significant positive effects, especially 
on individuals where severe systemic diseases prominently affect oro-dental structures; such as 
neuromuscular disorders, cancer-associated osteosequestrectomy and osteoporosis where bone 
density is reduced and sustained-releasing fluoride effects are necessary to adapt adequate treatment 
modalities. Also, the ascorbic acid (Vitamin C) present on the human body helps activate chitosan in 
the intestines leading to less cholesterol and fat absorption , aiding patients on dialysis procedures; 
as well as increasing insulin levels and decreasing blood glucose, which directly promotes general 
health and diminishes major affecting issues occurring within the oral cavity. (Fookesa, Mengattoa, 
Rigallib, & Luna, 2019) 
Chitosan hydrogel formulation appears to be stable on neutral Ph levels and stable on an 
approximately 48 hour period, where sodium fluoride, calcium and phosphate’s absorbability are 
most likely  to be increased; on which it is crucial for bone defects repair .  (Fookesa et al., 2019)   
Babrawala, et al, (2016) in their 9 months clinical trial using 15% chitosan gel as a bone graft 
in treating intrabony defects reported a significant PPD reduction of 5.8 ± 1.39 mm and a CAL gain 
of 5.8 ± 1.39 mm. Moreover, a greater reduction in IBD depth of 3.41 ± 1.17 mm and a defect 
resolution of 80.49 ± 7.50 % at 9 months. And this comes in agreement to this study results. 
On periodontology and implantology study fields, statistics were significant on clinical trials 
with moderate to minimal risk of bias, as chitosan brushing to remove dental biofilms were proved, 
stabilize bone layers, bleeding and healing sockets upon tooth extractions.  (Ezoddini-Ardakani et 
al., 2011; Zeza, Wohlfahrt, & Pilloni, 2017)    
Chitosan can enhance platelet adhesion and aggregation.(Ezoddini-Ardakani et al., 2011) . 
High concentrations of platelets or platelet-rich plasma release high levels of PDGF and TGF-b. 
(Jayasuriya & Kibbe, 2010) It was reported that chitosan can stimulate platelets to release these 
growth factors which are capable of regulating osseous- related activities. Platelets can contribute to 
mineralized tissue regeneration of by stimulation of. the mitogenic activity of bone cells, It is likely 
that in Chitosan presence with platelets and .related growth hormones enhance  heterotopic bone 
formation involving differentiation of mesenchymal cells in connective tissue into bone-forming 
cells. (Jeong Park et al., 2000; J.-Y. Lee et al., 2002; Mizuno et al., 2003; Oktay et al., 2010; Zhao et 
al., 2012)    
Compared with another study, (Boynueğri et al., 2009) in which Chitosan gel was applied for 
the treatment of chronic periodontitis and the reduction in PD values were reported as 1.21 mm for 
Chitosan, 1.48 mm for Chitosan  metronidazole and 0.94 mm for control sites, our study showed 
slightly superior results confirming that the use of Chitosan in infrabony defects enhanced bone fills 
in  periodontitis patients .However , future researches are needed to clarify the response to Chitosan 
treatment in different periodontitis stages and grades. 
 
Similarly, Babrawala, et al, (2016) reported better results were in comparison with another 
study done by (Akncbay et al, (2007), where chitosan gel was applied for the treatment of chronic 
periodontitis. It was noted that after 6 months there was a reduction in PPD by 1.21 mm for chitosan 
and 0.94 mm for the control 
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 Some infrabony defects in this study were three-walled defects, while others .were 
combination of one and two walls. Cortellini et al. (Cortellini, Prato, & Tonetti, 1995)  reported that 
two and three walled defects being highest potential for regeneration when grafting procedures were 
used. Moreover, there is strong evidence of better predictability with deep, narrow defects compared 
with shallow, wide ones. (Laurell, Gottlow, Zybutz, & Persson, 1998). However, it is challenging to 
control these variables in. human clinical trials, since it is impossible to obtain matched osseous 
defects. Therefore, the potential influence of this variability on the results needs to be recognized.  
When interpreting this study findings, it seems that gain in clinical attachment level concur 
with radiological findings. In addition, postsurgical healing revealed good soft tissue response to 
Chitosan gel with no complications. Furthermore, the patients’ good standards of oral hygiene 
improved the treatment outcome. 
Finally there is a need of well-designed studies to test novel regenerative approaches in the 
context of periodontal tissue regeneration with emphasis mainly on histologic evidence of periodontal 
regeneration.  
5. CONCLUSION 
Chitosan gel showed promising benefit in periodontal regeneration context among periodontitis 
patients. As it is a safe compound with no side effects observed, further researches should be carried 
to enroll chitosan on medical and dental practices. Moreover; modern new biomaterials should be 
improved to enhance their characteristics and increase the statistical significance clinically with very 
low bias for error and adequate criteria to carry any dental procedure involving periodontal tissues.  
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